Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Knut-Christian Gröntoft, Rutger Larsson, Henrik Mulec, Lars G. Weiss, John P. Dickinson. (1998) Effects of Ticlopidine in AV-fistula Surgery in Uremia. Scandinavian Journal of Urology and Nephrology 32:4, pages 276-283.
Read now
Read now
Articles from other publishers (42)
Patrizia Natale, Suetonia C Palmer, Valeria M Saglimbene, Marinella Ruospo, Mona Razavian, Jonathan C Craig, Meg J Jardine, Angela C Webster & Giovanni FM Strippoli. (2022) Antiplatelet agents for chronic kidney disease. Cochrane Database of Systematic Reviews 2022:2.
Crossref
Crossref
Imran Mohamed, Mohamad Fathul Aizat Kamarizan & Antonio Da Silva. (2021) Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts. Cochrane Database of Systematic Reviews 2021:7.
Crossref
Crossref
Te-I. Chang, Cheng-Hsien Chen, Hui-Ling Hsieh, Chun-You Chen, Shih-Chang Hsu, Ho-Shun Cheng, Wen-Cheng Huang, Yuh-Mou Sue, Yung-Ho Hsu, Feng-Yen Lin, Chun-Ming Shih, Shing-Jong Lin, Po-Hsun Huang & Chung-Te Liu. (2020) Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula. Scientific Reports 10:1.
Crossref
Crossref
Xiaole Su, Bingjuan Yan, Lihua Wang, Jicheng Lv, Hong Cheng & Yipu Chen. (2019) Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. BMC Nephrology 20:1.
Crossref
Crossref
Rebecca Hudson, David Johnson & Andrea Viecelli. 2019. Vascular Access Surgery - Tips and Tricks. Vascular Access Surgery - Tips and Tricks.
Jeeeun Park, Jinhae Kim, Subin Hwang, Mi Kyoung Lee, Hye Ryoun Jang, Jung Eun Lee, Yang-Jin Park, Wooseong Huh, Yoon-Goo Kim, Ha Young Oh & Dae Joong Kim. (2018) Arteriovenous graft patency outcomes and prognostic factors. Vascular 27:2, pages 128-134.
Crossref
Crossref
Andrea K. Viecelli, Ashley B. Irish, Kevan R. Polkinghorne, Carmel M. Hawley, David W. Johnson, Trevor A. Mori, Elaine M. Pascoe, Giovanni F.M. Strippoli, Charmaine E. Lok & Suetonia C. Palmer. (2018) Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials. American Journal of Kidney Diseases 72:1, pages 50-61.
Crossref
Crossref
Andrea K Viecelli, Trevor A Mori, Prabir Roy‐Chaudhury, Kevan R Polkinghorne, Carmel M Hawley, David W Johnson, Elaine M Pascoe & Ashley B Irish. (2017) The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled. Seminars in Dialysis 31:3, pages 244-257.
Crossref
Crossref
Felicitas L. Koller & Kenneth J. Woodside. 2017. Technological Advances in Organ Transplantation. Technological Advances in Organ Transplantation
87
115
.
M Field, D McGrogan, Y Marie, M Joinson, C Andujar, M Dutton, H Krishnan, J Hodson, D van Dellen & N G Inston. (2016) Randomized clinical trial of the use of glyceryl trinitrate patches to aid arteriovenous fistula maturation. British Journal of Surgery 103:10, pages 1269-1275.
Crossref
Crossref
N.C. Tanner & A.F. da Silva. (2016) Medical Adjuvant Treatment to Improve the Patency of Arteriovenous Fistulae and Grafts: A Systematic Review and Meta-analysis. European Journal of Vascular and Endovascular Surgery 52:2, pages 243-252.
Crossref
Crossref
Andrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, Carmel M Hawley, Peta-Anne Paul-Brent, Sunil V Badve, Alan Cass, David W Johnson, Peter G Kerr, Trevor A Mori, Anish Scaria, Seong L Hooi, Meng L Ong & Ashley B Irish. (2016) Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. Nephrology 21:3, pages 217-228.
Crossref
Crossref
Andrea K. Viecelli, Elaine Pascoe, Kevan R. Polkinghorne, Carmel Hawley, Peta-Anne Paul-Brent, Sunil V. Badve, Alan Cass, Stephane Heritier, Peter G. Kerr, Trevor A. Mori, Amanda Robertson, Hooi L. Seong & Ashley B. Irish. (2015) The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications. BMC Nephrology 16:1.
Crossref
Crossref
Nicola C Tanner & Anthony Da Silva. (2015) Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Kazutaka Kukita, Seiji Ohira, Izumi Amano, Hidemune Naito, Nakanobu Azuma, Kiyoshi Ikeda, Yutaka Kanno, Takashi Satou, Shinji Sakai, Tokuichiro Sugimoto, Yoshiaki Takemoto, Hiroaki Haruguchi, Jun Minakuchi, Akira Miyata, Noriyoshi Murotani, Hideki Hirakata, Tadashi Tomo & Tadao Akizawa. (2015) 2011 update Japanese Society for Dialysis Therapy Guidelines of Vascular Access Construction and Repair for Chronic Hemodialysis. Therapeutic Apheresis and Dialysis 19, pages 1-39.
Crossref
Crossref
Suetonia C Palmer, Lucia Di Micco, Mona Razavian, Jonathan C Craig, Vlado Perkovic, Fabio Pellegrini, Meg J Jardine, Angela C Webster, Sophia Zoungas & Giovanni FM Strippoli. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Suetonia C. Palmer, Lucia Di Micco, Mona Razavian, Jonathan C. Craig, Pietro Ravani, Vlado Perkovic, Gianni Tognoni, Giusi Graziano, Meg Jardine, Fabio Pellegrini, Antonio Nicolucci, Angela Webster & Giovanni F.M. Strippoli. (2013) Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis. American Journal of Kidney Diseases 61:1, pages 112-122.
Crossref
Crossref
Pierfrancesco Veroux, Alessia Giaquinta, Tiziano Tallarita, Nunziata Sinagra, Carla Virgilio, Domenico Zerbo, Peter Gloviczki & Massimiliano Veroux. (2013) Primary balloon angioplasty of small (≤2 mm) cephalic veins improves primary patency of arteriovenous fistulae and decreases reintervention rates. Journal of Vascular Surgery 57:1, pages 131-136.
Crossref
Crossref
A. J. Jackson, P. Coats & D. B. Kingsmore. (2012) Pharmacotherapy to improve outcomes in vascular access surgery: a review of current treatment strategies. Nephrology Dialysis Transplantation 27:5, pages 2005-2016.
Crossref
Crossref
. (2011) . Nihon Toseki Igakkai Zasshi 44:9, pages 871-874.
Crossref
Crossref
William D. Paulson, Louise Moist & Charmaine E. Lok. 2011. Essentials of Percutaneous Dialysis Interventions. Essentials of Percutaneous Dialysis Interventions
23
49
.
C. I. Coleman, L. A. Tuttle, C. Teevan, W. L. Baker, C. M. White & K. M Reinhart. (2010) Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysis. International Journal of Clinical Practice 64:9, pages 1239-1244.
Crossref
Crossref
M. Hollenbeck, V. Mickley, J. Brunkwall, H. Daum, P. Haage, J. Ranft, R. Schindler, P. Thon & D. Vorwerk. (2009) Gefäßzugang zur HämodialyseVascular access for hemodialysis. Der Nephrologe 4:2, pages 158-176.
Crossref
Crossref
Charmaine E. Lok & Louise Moist. (2008) More Than Reducing Early Fistula Thrombosis Is Required: Lessons From the Dialysis Access Consortium Clopidogrel Fistula Study. American Journal of Kidney Diseases 52:5, pages 834-838.
Crossref
Crossref
Gary Osborn, Xavier Escofet & Anthony Da Silva. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Kevan Polkinghorne. (2008) Pharmacological approaches to preventing vascular access failure. Nephrology 13, pages S12-S16.
Crossref
Crossref
A. Sharathkumar, R. Hirschl, S. Pipe, C. Crandell, B. Adams & J.J. Lin. (2018) Primary Thromboprophylaxis with Heparins for Arteriovenous Fistula Failure in Pediatric Patients. The Journal of Vascular Access 8:4, pages 235-244.
Crossref
Crossref
Laura M Dember, James S Kaufman, Gerald J Beck, Bradley S Dixon, Jennifer J Gassman, Tom Greene, Jonathan Himmelfarb, Lawrence G Hunsicker, John W Kusek, Jeffrey H Lawson, John P Middleton, Milena Radeva, Steve J Schwab, James F Whiting & Harold I Feldman. (2016) Design of the Dialysis Access Consortium (DAC) clopidogrel prevention of early AV fistula thrombosis trial. Clinical Trials 2:5, pages 413-422.
Crossref
Crossref
Harold I. Feldman, Marshall Joffe, Sylvia E. Rosas, J.Eileen Burns, Jill Knauss & Kenneth Brayman. (2003) Predictors of successful arteriovenous fistula maturation. American Journal of Kidney Diseases 42:5, pages 1000-1012.
Crossref
Crossref
AF Da Silva, X Escofet & PA Rutherford. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Marian Goicoechea, Carlos Caramelo, Antonio Ochando, Concepción Andrea, Rosa Garvía & Alberto Ortiz. (2000) Antiplatelet therapy alters iron requirements in hemodialysis patients. American Journal of Kidney Diseases 36:1, pages 80-87.
Crossref
Crossref
James S. Kaufman. (2001) Antithrombotic Agents and the Prevention of Access Thrombosis. Seminars in Dialysis 13:1, pages 40-46.
Crossref
Crossref
Raymond Hakim & Jonathan Himmelfarb. (1998) Hemodialysis access failure: A call to action. Kidney International 54:4, pages 1029-1040.
Crossref
Crossref
David W. Windus, Samuel A. Santoro, Ralph Atkinson & Henry D. Royal. (1997) Effects of antiplatelet drugs on dialysis-associated platelet deposition in polytetrafluoroethylene grafts. American Journal of Kidney Diseases 29:4, pages 560-564.
Crossref
Crossref
Tom Buur, Rutger Larsson, Ulf Berglund, Francois Donat & Claude Tronquet. (2013) Pharmacokinetics and Effect of Ticlopidine on Platelet Aggregation in Subjects with Normal and Impaired Renal Function. The Journal of Clinical Pharmacology 37:2, pages 108-115.
Crossref
Crossref
S. Milutinović, V. Gašparovlć, E. Milutinović & J. Buturovlć-Ponikvar. (2018) Ticlopidine Improves Dialysis Clearance of Solutes in Uremic Patients by Reducing Blood Clotting in Dialyser Fibers. The International Journal of Artificial Organs 16:5, pages 249-252.
Crossref
Crossref
David W. Windus. (1993) Permanent Vascular Access: A Nephrologist's View. American Journal of Kidney Diseases 21:5, pages 457-471.
Crossref
Crossref
Edouard Panak & Monique Verry. 1993. Ticlopidine, Platelets and Vascular Disease. Ticlopidine, Platelets and Vascular Disease
13
25
.
Douglass T. Domoto, Joan E. Bauman & J.Heinrich Joist. (1991) Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thrombosis Research 62:6, pages 737-743.
Crossref
Crossref
D. Blockmans & J. Vermylen. (2018) Thrombogenicity of Artificial Organs. The International Journal of Artificial Organs 13:11, pages 723-728.
Crossref
Crossref
M. Verstraete. (1990) Les anti-agrégants en 1990. La Revue de Médecine Interne 11:3, pages 209-215.
Crossref
Crossref
Raymond Limet, Jean-Louis David, Paul Magotteaux, Marie-Paule Larock & Pierre Rigo. (1987) Prevention of aorta-coronary bypass graft occlusion. The Journal of Thoracic and Cardiovascular Surgery 94:5, pages 773-783.
Crossref
Crossref